Approvals/CIMA-AEMPS/TEICOPLANINA HIKMA 100 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION

Approved

STANDARD

TEICOPLANINA HIKMA 100 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION

Hikma Farmaceutica (Portugal) S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: a6834cdff3e5235a
Drug Cima Aemps Name: TEICOPLANINA HIKMA 100 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION
Register Number: 90379
Holder Company Name: Hikma Farmaceutica (Portugal) S.A.
Marketing Company Name: Hikma Farmaceutica (Portugal) S.A.
Holder Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a
Marketing Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a
Authorization Date: 2026-09-10
Dosage Form: POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN
Dose: 100 mg
Route Of Administration: VÍA INTRAMUSCULAR, VÍA INTRAVENOSA, VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Hikma Farmaceutica (Portugal) S.A.
Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 10, 2026

Approval ID

a6834cdff3e5235a

Type

Standard